We are live on ! Find out more
ATRC icon

AtriCure

221 hedge funds and large institutions have $1.62B invested in AtriCure in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 77 increasing their positions, 66 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

626% more call options, than puts

Call options by funds: $1.05M | Put options by funds: $145K

32% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 28

17% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 66

14% more capital invested

Capital invested by funds: $1.42B → $1.62B (+$202M)

7.61% more ownership

Funds ownership: 95.4%103% (+7.6%)

4% more funds holding

Funds holding: 213221 (+8)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
221
Holders Change
+8
Holders Change %
+3.76%
% of All Funds
2.96%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
37
Increased
77
Reduced
66
Closed
28
Calls
$1.05M
Puts
$145K
Net Calls
+$907K
Net Calls Change
-$205K

ATRC Hedge Fund Activity: Q1 2025 in Review

221 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2025, worth a combined $1.62B — up 14% from $1.42B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ATRC positions and 28 closed out — a net gain of 9 holders — while 77 added to existing stakes and 66 trimmed.

The largest buyer was UBS AM, adding an estimated $51.4M. The largest seller was First Light Asset Management, cutting an estimated $24.3M.

  • 221 institutional investors held AtriCure (ATRC) as of Q1 2025, up from 213 in Q4 2024.
  • Funds reported $1.62B of AtriCure stock for Q1 2025, up 14% quarter-over-quarter.
  • 37 funds opened new AtriCure positions in Q1 2025 and 28 closed out, a net change of +9 holders.
  • The largest AtriCure buyer in Q1 2025 was UBS AM, an estimated $51.4M added.
  • The largest AtriCure seller in Q1 2025 was First Light Asset Management, an estimated $24.3M sold.

Based on aggregated 13F filings for Q1 2025.